← Evidence map

ReviewBone marrow transplantation2026

How could calreticulin-targeting therapies change the myelofibrosis transplant paradigm?

Amy MacDonald et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42919838